Azafaros
PrivateLast Round
Series B
May 13, 2025
Total Funding Raised
$174.68M
Momentum Score
25 /100
Company Overview
Azafaros is a biopharmaceutical company specializing in therapeutic agents for the treatment of rare metabolic disorders through the oral administration of aza-sugar compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azafaros Comps
Public and private peers based on sector, stage, and business model.
Azafaros Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2025 | ||||
| Series A | Feb 6, 2020 | ||||
| Seed | Jul 23, 2018 |
Key People
Founding team and executive leadership
Azafaros Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series B |
| Asahi Kasei Pharma Venture Capital | Series B |
| BioMedPartners | Series B, Series A |
| Asahi Kasei Therapeutics Venture Capital | Series B |
| Seroba Life Sciences | Series B |
| Forbion Ventures | Series B |
| Forbion Growth Opportunities Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Will present at J.P. Morgan's 44th Annual Healthcare Conference.
- Jun 9, 2025
Will present at the BIO International Convention 2025.
Azafaros Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Azafaros's valuation, stock price, and market status.
